In summary, as a potential target, the elevated expression level of LRP6 protein is strongly correlated with malignancy and the poor prognosis of tumors, and targeting LRP6 may provide a new approach for the treatment of complex diseases, such as cancer, atherosclerosis, and Alzheimer’s disease. Here, LRP6 is linked to early-onset autosomal dominant Alzheimer disease.